Epilepsy Conferences | Epilepsy Congress | Epilepsy Treatment Conferences | Epilepsy Seizures Conferences | Neurology Conferences | CME Conferences | Vienna | Austria | Europe | USA | Middle East

Theme: The comprehensive evaluation and treatment of Epilepsy

Epilepsy 2019

Scientific Program

Renowned Speakers

Ramon Bautista
University of Florida HSC Jacksonville
USA

Alcibiades J. Rodriguez
NYU School of Medicine
USA

Alain L Fymat
International Institute of Medicine and Science
USA

Rapita Naresh Sood
McGill University
Canada

Alberto Musto
Eastern Virginia Medical School
USA

Tomokatsu Hori
Tokyo University
Japan

Leon Isaemidis
Louisiana Tech University
USA

Mootaz Salman
Shefield Hallam University
UK

M. M. Khan
Scientist,Univ. of Iowa Hospitals and Clinics
USA

Daqing
Imperial College London
UK

George Perry
The University of Texas
USA

Yawu Liu
Kuopio Univ. Hospital
Finland

Jennifer DeFeo
Chicago School of Prof.Psychology
USA

Kurt Jellinger
Inst. of Clinical Neurobiology
Austria

Guy H Fontaine
HÃ´pital de la SalpÃªtriÃ¨re
France

Kuldip Sidhu
Cell Therapeutics Pty Ltd
Australia

Fabio Grizzi
Laboratory of Molecular Gastroenterology of the Humanitas Clinical and Research Center
Italy

William Cho
Queen Elizabeth Hospital
Hong Kong

Xin Wang
Harvard Medical School
USA

Lucia M. Vaina
Massachusetts Gen. Hosp.
USA

Zameel Cader
Nuffield college
UK

Tang Wai Kwong
Shatin Hospital Hong Kong
Hong Kong

Davide Moretti
National Institute of Research and Cure for Mental disorders and Dementia
Italy

Dhavendra Kumar
University Hospital of Wales
UK

Chethan P. V. Rao
Baylor College of Medicine
USA

Martina Bebin
UAB Epilepsy Center
USA

O. Nuri Ozgirgin
Proffessor Bayindir Hospital
Turkey

Insop Shim
Kyung Hee University
South Korea

Xavier F Figueroa
Pontifical Catholic University
Chile

Peter Silburn
The University of Queensland
Australia

Galina Mindlin
Mount Sinai
USA

Bibiana Bielekova
Professor National Institutes of Health
USA

Allal Boutajangout
New York University Langone Medical Center
USA

Giulio Maria Pasinetti
Icahn School of Medicine at Mount Sinai
USA

Karolina Can
University in GÃ¶ttingen
Germany

Fares Nigim
Harvard Medical School
USA

Zoi A Giavri
Advantis Medical Imaging
Greece

Adam Mate
Stroke Association
Australia

Malcolm Hooper Oxymed, Australia Austra
Oxymed
Australia

Judit Subirana-Mirete
Ramon Llull University
Spain

Selma Pelaez
Selma Pelaez UManresa-FUB
Spain

Isabel Lastres-Becker
Autonomous University of Madrid
Spain

Anthony E Kline
University of Pittsburgh
USA

Evelyn M Garcia
Carilion Clinic
USA

Ann Marie Gillie
Epilepsy Advocate
Democratic Republic of the Congo

Galia Valentinova Anguelova
Leiden University Medical Centre
Netherlands

Parreira M
University of Minho
Portugal

Maia Machvariani-Tsereteli
Ivane Javakhisvili Tbilisi State University
Georgia

Yuri P Danilov
University of Wisconsin-Madison
USA

FrÃ©dÃ©ric Haesebaert
Lyon Neuroscience Research Center
France

Shao-Jun Tang
University of Texas
USA

Wolfram Kersten
Mind-up GmbH & CO.KG â€“ Bamberg
Germany

Trevor Archer
Professor University of Gothenburg
Sweden

Suresh Kumar
Director TBI & Memory Research Institute & Regain Memory Center
USA

Charles W Graham
Community College of Aurora
USA

Xavier F Figueroa
Pontifical Catholic University of Chile
Chile

Adinda Prawityasari Kusubandio
KAPETA Foundation
Indonesia

Peter Poortvliet
University of Queensland
Australia

Amir Tamiz
National Institute of Health
USA

Frank Galimidi
New Beginnings Recovery Center
USA

Konstantin Slavin
University of Illinois
USA

Peter Kaplan
Johns Hopkins University
USA

Lucia M. Vaina
Boston University College of Engineering
USA

Markku Kurkinen
Wayne State University School of Medicine
USA

Deborah Oliveira
University of Nottingham
UK

Diana Kljenak
Ontario Psychiatric Association
Canada

Wen-Hai Chou
National Health Research Institute
Taiwan

Ljudmila Stojanovich
Belgrade University
Serbia

Felipe Padilla Vazquez
Vascular and Endovascular Center
Mexico

David Truswell
Culture Dementia
UK

Walter E. Muller
University of Frankfurt
Germany

Jacqueline A Hinds
Society of Emotional Intelligence
UK

BogusÅ‚awa Budziszewska
Institute of Pharmacology, Polish Academy of Sciences
Poland

Doo Soo Chung
Seoul National University
South Korea

Kirk J. Ziegler
University of Florida
USA

Ivanka Zivcic Becirevic
University of Rijeka
Croatia

Olivier Dapremont
AMPAC Fine Chemicals LLC
USA

Hans von Holst
Royal Institute of Technology
Sweden

Arunkumar Umesh Prasadagic
Taishan Medical University
China

Chan Kam Tim Michael
Association of Integrative Aesthetic Medicine
Hong Kong

Alok Sharma
NeuroGen Brain & Spine Institute
India

Marina Zueva
Moscow Helmholtz Research Institute of Eye Diseases Russian Federation
Russia

Ayman W El-Hattab
Tawam Hospital
UAE

Felix-Martin Werner
Euro Academy Pobneck
Germany

Joanna B. Strosznajder
Polish Academy of Sciences
Poland

Eef Hogervorst
Loughborough University
UK

Kay Ohlendieck
Maynooth University
Ireland

Giovanni Antioco Putzu
Casa di Cura Santâ€™Elena
Italy

Safa Shehab
UAE University
UAE

Roberto Cartolari
Regional Hospital of Bellinzona and Valleys San Giovanni
Switzerland

James Gratwicke
The National Hospital for Neurology and Neurosurgery
UK

Ute-Christiane Meier
Queen Mary University London
UK

Mohamed A Fahmy Zeid
Alexandria University
Egypt

Francesco Massari
University of Massachusetts Medical School
USA

Haifa Al Issa
King Saud bin Abdulaziz University for Health Sciences
Saudi Arabia

Sybille Krauss
Neurodegenerative Erkrankungen
Germany

Fan Fan
University of Mississippi Medical Center
USA

Susan Hosseini Nasab
The University of Texas Health Science Center
USA

Bo Feng
University of Hong Kong
Hong Kong

Regina Esiovwa Ahumareze
University of the West of Scotland
UK

Jeffrey M. Chung
Cedars-Sinai Medical Center
USA

Sharon Ceanna Fernando
Syneos Health
USA

Michele Roccella
University of Palermo
Italy

Long-Jun Wu
Mayo Clinic
USA

Ann Hanafy
Cairo University
Egypt

Joey Gaines
USA
USA

Marco Carotenuto
University of Campania "Luigi Vanvitelli"
Italy

Yo-Tsen Liu
National Yang-Ming University
Taiwan

Epilepsy 2019

Epilepsy 2019 welcomes attendees, participants, students, speakers, organizing committee members, delegates from all over the world to Vienna, Austria. We are delighted to invite you to our 5^th International Conference on Epilepsy & Treatment 2019 on August 29-30, 2019 at Vienna, Austria

Session on Neurobiology of Epilepsy

Epilepsy is a chronic disorder with diverse clinical characteristics that preclude a singular mechanism a neurological disorder marked by sudden recurrent episodes of seizures due to disturbances in electrical signalling and its transmission in the brain. The fact that multiple mechanisms exist is not surprising given the varied ways the normal nervous system controls this balance. In contrast, understanding seizures in the brain of an individual with epilepsy is more difficult because seizures are typically superimposed on an altered nervous system.

Aetiology and Epileptogenesis of epilepsy
Parts of brain involved in epilepsy
Phases of epilepsy
Types of epilepsy

5^th International Conference on Epilepsy & Treatment, August 29-30, 2019 Vienna, Austria; 28^th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7^thInternational Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32^ndEuropean Neurology Congress, July 22-24, 2019 London, UK; Austria; 23^rd International Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Session on Epilepsy in Paediatrics

Epilepsy affects around 1 in every 200 children and young people under 18 Children having idiopathic. Epilepsy has 90% chances of getting rid of Epilepsy at their 20’s. Epilepsy is most common in children and adults having age more than 60

Epilepsy in gender& age
Seizures in childhood

5^th International Conference on Epilepsy & Treatment, August 29-30, 2019 Vienna, Austria; 11^thInternational Conference on Vascular Dementia February 15-16, 2019 Amsterdam, Netherlands; Annual Congress on Neurology & Neuroscience March 14-15, 2019 Paris, France; 24^th International Conference on Neurosurgery and Neuroscience March 18-20, 2019 Edinburgh, Scotland; 5^th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 8^th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France

Session on Epilepsy Devices

Seizure alert devices are useful in letting family members know if a seizure is occurring, especially parents of young children

Neurostimulator
Mattress devices
Cameras
Anti-suffocation pillows
Smart watches
Medic Alert bracelet

7^th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32^nd European Neurology Congress, July 22-24, 2019 London, UK; 5^th World Congress on Parkinson’s & Huntington Disease, August 29-31, 2019 Vienna, Austria; 5^th International Conference on Epilepsy & Treatment, August 29-30, 2019 Vienna, Austria; 23^rd International Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Session on Epilepsy & Pregnancy

Women with Epilepsy have fewer chances to conceive than in non-epileptic women. For women who want marriage or pregnancy, special consideration is necessary, with the single use of commonly used antiepileptic drugs, the malformation incidence and the stillbirth rate will increase to 2 to 3 times of the general population

Pregnancy and motherhood
Labour and delivery
Family history
Brain infections

Session on Prevention & Management of Epilepsy

Maintaining Ketogenic diet, regular exercise can reduce the risk of Epilepsy, get plenty of sleep during nights and avoid using drugs and alcohol. Epilepsy due to medication can be subsided by discontinuing the medicines, controlling stress, anxiety & other emotional issues can reduce the risk of Epileps y

Alcohol Rehabilitation
Brain Exercise
Ketogenic diet

24^th International Conference on Neurosurgery and Neuroscience March 18-20, 2019 Edinburgh, Scotland; 5^th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 8^th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France; 5^th International Conference on Epilepsy & Treatment, August 29-30, 2019 Vienna, Austria

Session on Seizure First Aid and Safety

About 1 out of 10 people has had a seizure. That means seizures are common, and one day you might need to help someone during or after a seizure. Learn what you can do to keep that person safe until the seizure stops by itself

11^thInternational Conference on Vascular Dementia February 15-16, 2019 Amsterdam, Netherlands; Annual Congress on Neurology & Neuroscience March 14-15, 2019 Paris, France; 24^th International Conference on Neurosurgery and Neuroscience March 18-20, 2019 Edinburgh, Scotland; 5^th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 8^th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France

Session on SUDEP: Sudden unexplained death in epilepsy

Sudden unexplained death in epilepsy (SUDEP) accounts for 7–17% of deaths among people with epilepsy. Patients with uncontrolled seizures are at greatest risk for SUDEP, and experiencing tonic-clonic seizures, taking multiple antiepileptic drugs and having coexisting neurologic disease further increase the risk.

Session on Non-Surgical Treatment of Epilepsy

If Anti-epileptic drugs aren’t controlling your seizures and brain surgery isn’t suitable for you, there are other procedures that could help

5^th International Conference on Epilepsy & Treatment , August 29-30, 2019 Vienna, Austria; 11^thInternational Conference on Vascular Dementia February 15-16, 2019 Amsterdam, Netherlands; Annual Congress on Neurology & Neuroscience March 14-15, 2019 Paris, France; 24^th International Conference on Neurosurgery and Neuroscience March 18-20, 2019 Edinburgh, Scotland; 5^th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 8^th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France

Session on Herbal Treatments for Epilepsy

Before modern seizure medicines were developed, people with epilepsy and their doctors looked for a remedy in various herbs and combinations of herbs. Good news is, there are some natural remedies for seizures. Before advanced seizure medications were even discovered, doctors used herbs to treat this condition. He rbs for seizures are still used today because of their impressive effectiveness

Session on Homeopathic treatment of Epilepsy

Epilepsy can be treated in a number of ways. One of the most preferred forms of treatment is homeopa thy. Homeopathy addresses both the physical symptoms of the disease and the underlying factors triggering it. Another big advantage of homeopathic treatment is that it has negligible side effects

Session on Epilepsy Surgery

Removing a portion of the brain . The most common type of epilepsy surgery is the removal of the portion of the brain usually about the size of a golf ball that’s causing the seizures. This type of surgery — called resective surgery can remove a lobe, a portion of a lobe or a lesion and is highly successful

7^th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32^nd European Neurology Congress, July 22-24, 2019 London, UK; 5^th World Congress on Parkinson’s & Huntington Disease, August 29-31, 2019 Vienna, Austria; 5^th International Conference on Epilepsy & Treatment , August 29-30, 2019 Vienna, Austria; 23^rd International Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Session on Immunomodulatory Treatments in Epilepsy

The role of immunity and inflammation appears to be an integral part of the pathogenic processes associated with some seizures, particularly with refractory epilepsy. Prompt treatment with immunotherapy may lead to better outcomes. Immune treatment options for treatment of epilepsy include therapies such as corticosteroids, immunoglobulin’s, plasmapheresis, or steroid-sparing drugs such as azathioprine

Session on Metacognitive beliefs in Epilepsy

Emotional distress is common in people with epilepsy (PWE) for which efficacious interventions are required. Developing evidence-based treatments should be based on testable models of the psychological mechanisms maintaining psychopathology. The Self-Regulatory Executive Function (S-REF) model proposes that maladaptive metacognitive beliefs and processes are central to the development and maintenance of emotional distress. Although preliminary support exists for the role of metacognitive beliefs in emotional distress in PWE, their role has yet to be tested when controlling for the contribution made by illness perceptions

5^th International Conference on Epilepsy & Treatment, August 29-30, 2019 Vienna, Austria; 28^th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7^th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32^nd European Neurology Congress, July 22-24, 2019 London, UK; Austria; 23^rd International Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Session on Cannabinoids in treatment of resistant Epilepsy

The interest in cannabis-based products for the treatment of refractory epilepsy has skyrocketed in recent years. Treatment-resistant epilepsy (TRE) affects 30% of epilepsy patients and is associated with severe morbidity and increased mortality. Cannabis-based therapies have been used to treat epilepsy for millennia, but only in the last few years have we begun to collect data from adequately powered placebo-controlled, randomized trials (RCTs) with cannabidiol (CBD), a cannabis derivative

Session on Cognitive Disorders of Epilepsy

Cognitive disorders are common in patients with epilepsy. Their aetiology is multifactorial, being affected by the type and location of the epileptogenic lesion, epileptic syndrome, type of seizures, age of onset, frequency and severity. Timely diagnosis and treatment can help to reduce their impact on the patient’s quality of life

11^th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam, Netherlands; Annual Congress on Neurology & Neuroscience March 14-15, 2019 Paris, France; 24^th International Conference on Neurosurgery and Neuroscience March 18-20, 2019 Edinburgh, Scotland; 5^th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 8^th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France

Session on Advanced Epilepsy Diagnosis Assessment

Doctors have developed when an individual experience a seizure for the first time doctors advices him for EEG and observes for abnormality in the of EEG these tests differentiate patient from epileptic to non- epileptic .Research suggests that patients are only suggested to medicated for epilepsy only after their occurrence of second seizure. Many non-epileptic patients experience an unusual brain activity so; it is advised to record EEG while sleeping is preferable. Brain scan like CT- SCAN are used

Session on Epilepsy Therapeutics & Drug therapy

Majorly epilepsy is treated with antiepileptic drugs primarily first line drugs like carbamazepine, valproate, phenytoin, carbazepine whereas, second generation include zonisamide and lacosamide are showing good efficacy with low adverse effects. Ethosuximide is majorly used for primary treatment. Diazepam is now available as rectal gel so that can be applied by family members for prolonged seizures. Drug combination sometimes lead to adverse effects like fatigue and loss of appetite so, combinations are often replaced by monotherapy unless monotherapy achieves desired results. When medication doesn’t achieve the required targets doctor can sometimes suggest for surgery 64% cases showed seizure free cases who undergone surgery

11^th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam, Netherlands; Annual Congress on Neurology & Neuroscience March 14-15, 2019 Paris, France; 24^th International Conference on Neurosurgery and Neuroscience March 18-20, 2019 Edinburgh, Scotland; 5^th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 8^th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France

Session on Highly marketed and used drugs of Epilepsy

The global market for Antiepileptic drugs is driven by advancement in drugs modification. Over the past several periods, the number of available Antiepileptic drugs has more than doubled. , many of the presently available Antiepileptic drugs have basics pharmacokinetics and more small effects on liver metabolism that converts into a lower rate of side effects, The antiepileptic drug market is threatened by generic competition, which has risen dramatically in the face of patent expirations among various major branded Antiepileptic drugs. These are the major restraints for the Global antiepileptic drugs market

Session on Epilepsy Case Reports

According to WHO, It is estimated that every year nearly 2.4 million people are diagnosed with Epilepsy and there are 4 to 5 in a group of 1000 people with active Epilepsy. Nearly 80% of the individuals with Epilepsy is found in developing regions, Epilepsy represents 0.6%, of the worldwide weight of sickness

Epilepsy 2019 welcomes attendees, participants, students, speakers, organizing committee members, delegates from all over the world to Vienna, Austria. We are delighted to invite you to our 5^th International Conference on Epilepsy & Treatment on August 29-30, 2019.

Epilepsy 2019 is the gathering of scientists, neurologists, speakers, professors, business delegates and students all over the world to participate to discover the new novel therapeutics of Epilepsy, where people can get desired knowledge over Epilepsy and recent inventions on Epilepsy Treatmen t. We are glad to invite you at Epilepsy 2019 where you can experience a really sumptuous information and knowledge on Epilepsy management

Importance and Scope:

Epilepsy is a chronic disorder usually occurred in children and people aged above 60 years. A neurological disorder marked by sudden recurrent episodes of seizures with loss of consciousness. It is associated with abnormal electrical activity in the brain with the loss of consciousness; it may be of different types and with different episodes of seizures from person to person. Epilepsy is a non-communicable disease with approximately 50 million people in the world suffers from this disease. People with Epilepsy respond to treatment approximately within 70% of the time. About three-fourths of people with Epilepsy living in low- and middle- income countries do not get the treatment properly as they need. In many parts of the world, people with Epilepsy and their families suffer from stigma and discrimination. It is estimated that every year nearly 2.4 million people are diagnosed with Epilepsy and there are 4 to 5 in a group of 1000 people with active Epilepsy. Nearly 80% of the individuals with Epilepsy is found in developing regions.

Target Audience:

Pharmaceutical Industries

Researchers in Epilepsy

Epilepsy Foundations

Epilepsy Diagnosis Centres

On behalf of 5th International Conference on Epilepsy & Treatment 2019, it is very glad in inviting you all attendees, participants, students, speakers, organizing committee members, delegates from all over the world to Vienna, Austria on August 29-30, 2019.

Epilepsy 2019 is the gathering of scientists, neurologists, speakers, professors, business delegates and students all over the world to participate to discover the new novel therapeutics of Epilepsy, where people can get desired knowledge over Epilepsy and recent inventions on Epilepsy treatment. We are glad to invite you at Epilepsy 2019 where you can experience a really sumptuous information and knowledge on Epilepsy management.

Reasons to Undertake

Epilepsy can affect every one of us In Europe, at least 6 million people have epilepsy, and 15 million Europeans will have one seizure at some time in their lives. Nevertheless, in some countries of Europe, epilepsy is not recognized as a brain disorder and up to 40% of people with this condition may be untreated - the treatment gap.

Antiepileptic drugs are not always available or are not affordable and diagnostic facilities are lacking or are inadequate. It has been estimated that the 6 million people with active epilepsy in Europe cost over € 20 billion per year, and despite this, very few European countries have national plans for managing the disorder.

The 6 million people with epilepsy in Europe want to bring epilepsy “out of the shadows”.

Conference Highlights:

Neurobiology of Epilepsy	Epilepsy Devices
Epilepsy in Pediatrics	Epilepsy Surgery
Epilepsy & Pregnancy	Immunomodulatory Treatments in Epilepsy
Prevention and Management of Epilepsy	Metacognitive beliefs in Epilepsy
Seizure First Aid and Safety	Cannabinoids in treatment of resistant Epilepsy
SUDEP: Sudden unexplained death in epilepsy	Cognitive Disorders of Epilepsy
Ketogenic diet	Advanced Epilepsy Diagnosis Assessment
Non-Surgical Treatment of Epilepsy	Epilepsy Therapeutics & Drug therapy
Herbal Treatments for Epilepsy	Highly marketed and used drugs of Epilepsy
Homeopathic treatment of Epilepsy	Epilepsy Case Reports

Why Vienna, Austria?

Vienna was the world's number-one destination for international congresses and conventions. It attracts over 6.8 million tourists a year. Austria was the cradle of numerous scientists with international reputation. Vienna regularly hosts urban planning conferences and is often used as a case study by urban planners. The city of Vienna attaches major importance to science and research and focuses on creating a positive environment for research and development. A major R&D sector in Vienna are life sciences with 378 biotech, pharma and medtech companies.

Top Hospitals in the World

1. Cleveland clinic

2. St Jude children’s research hospital

3. Johns Hopkins Medicine

4. Mayo Clinic Scottsdale AZ

5. University of Maryland medical center

6. M D Anderson cancer center

7. Massachusetts general hospital

8. Assistance Sloan Kettering cancer center

Top Hospitals in Europe:

1. Grupo Hospitalario Quirón

2. Hygeia Hospital

3. Max Grundig Klinik

4. Sant Joan de Déu-Barcelona Children’s Hospital

5. Privatklinik Döbling

6. British Hospital Lisbon XXI

7. Medipol Mega University Hospital

8. Centre Chirugical AMBROISE-PARÉ

9. University Medical Center Hamburg-Eppendorf

Top Hospitals in Austria:

1. Rudolfinerhaus

2. Elisabethinen Hospital Graz

3. St. Josef Hospital Vienna

4. Confraternity Private Clinic Josefstadt

5. Franziskus Spital highway

6. Landeskrankenhaus Graz South-West, Location South

7. EB House Austria

Universities in the World:

1. Massachusetts Institute of Technology

2. Stanford University

3. Harvard University

4. California Institute of Technology

5. University of Oxford

6. University College London

7. University of Chicago

8. ETH Zurich

Universities in the Austria:

1. Alps-Adriatic University Klagenfurt

2. Danube University Krems

3. Graz University of Technology

4. Johannes Kepler University of Linz

5. Medical University of Graz

6. Medical University of Vienna

7. Medical University Innsbruck

8. Modul University Vienna

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	August 29-30, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View